Radionuclide treatment for painful bone metastases in patients with hormone-refractory prostate cancer

被引:0
|
作者
Dolezal, J. [1 ]
机构
[1] Teaching Hosp, Hradec Kralove, Czech Republic
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S350 / S350
页数:1
相关论文
共 50 条
  • [21] Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer
    Brown, RSD
    Edwards, J
    Dogan, A
    Payne, H
    Harland, SJ
    Bartlett, JMS
    Masters, JRW
    JOURNAL OF PATHOLOGY, 2002, 198 (02): : 237 - 244
  • [22] Pyrazoloacridine for the treatment of hormone-refractory prostate cancer
    Small, EJ
    Fippin, LJ
    Whisenant, SP
    CANCER INVESTIGATION, 1998, 16 (07) : 456 - 461
  • [23] Chemotherapy for the treatment of hormone-refractory prostate cancer
    Petrylak, DP
    EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (02) : 15 - 23
  • [24] Chemotherapy for patients with hormone-refractory prostate cancer
    Joly, F
    Tannock, IF
    ANNALS OF ONCOLOGY, 2004, 15 (11) : 1582 - 1584
  • [25] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [26] Economic evaluation of denosumab compared with zoledronic acid in patients with hormone-refractory prostate cancer with bone metastases.
    Yu, A. P.
    Namjoshi, M.
    Xie, J.
    Parikh, K.
    Wu, E. Q.
    Guo, A.
    Culver, K. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] Hormone-refractory prostate cancer
    Alexandre, I.
    Rixe, O.
    ANNALES D UROLOGIE, 2007, 41 (02) : 47 - 55
  • [28] Re: Economic Evaluation of Denosumab Compared With Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients With Bone Metastases
    Schmid, Hans-Peter
    Theiler, Robert
    EUROPEAN UROLOGY, 2012, 61 (02) : 427 - 428
  • [29] A role of somatostatin analogues in the treatment of patients with hormone-refractory prostate cancer
    Alekseev, B. Ya.
    Kaprin, A. D.
    Nyushko, K. M.
    ONKOUROLOGIYA, 2011, 7 (02): : 84 - 87
  • [30] Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?
    Oh, William K.
    Tay, Miah-Hiang
    Huang, Jiaoti
    CANCER, 2007, 109 (03) : 477 - 486